Skip to content
Formerly Glenmark Life Sciences Limited
  • I
  • CONTACT US
  • I
  • FOLLOW US
logo_alivus
  • ABOUT US
    • Who we are
    • What we do
    • Our Evolution
    • Our Heritage
    • Our Leadership
    • Our Board of Directors
  • SOLUTIONS AND SERVICES
    • APIs & CDMO
    • End to end support
  • INFRASTRUCTURE
    • R&D
    • Manufacturing
  • SUSTAINABILITY
    • Responsibility at a Glance
    • Environmental Initiatives
    • Community Initiatives
    • Responsibility reports
  • INVESTORS
    • Shareholders Corner
      • Corporate Governance Report
      • Statement of Investor Complaints
      • Shareholding Pattern
      • Reconciliation of Share Capital Audit Report
      • Intimations to Stock Exchanges/Disclosures/Latest Announcements
      • Dividend/Unclaimed Dividend
    • Corporate Governance
    • Disclosures as per regulation 46 of SEBI (LODR) 2015
    • Financials
      • Financial Results
      • Reports and Presentations
  • MEDIA
    • Press Releases
    • News
    • Videos
  • CAREERS
    • Our Culture
    • Join us
MENU CLOSE
  • ABOUT US
    • Who we are
    • What we do
    • Our Evolution
    • Our Heritage
    • Our Leadership
    • Our Board of Directors
  • SOLUTIONS AND SERVICES
    • APIs & CDMO
    • End to end support
  • INFRASTRUCTURE
    • R&D
    • Manufacturing
  • SUSTAINABILITY
    • Responsibility at a Glance
    • Environmental Initiatives
    • Community Initiatives
    • Responsibility reports
  • INVESTORS
    • Shareholders Corner
      • Corporate Governance Report
      • Statement of Investor Complaints
      • Shareholding Pattern
      • Reconciliation of Share Capital Audit Report
      • Intimations to Stock Exchanges/Disclosures/Latest Announcements
      • Dividend/Unclaimed Dividend
    • Corporate Governance
    • Disclosures as per regulation 46 of SEBI (LODR) 2015
    • Financials
      • Financial Results
      • Reports and Presentations
  • MEDIA
    • Press Releases
    • News
    • Videos
  • CAREERS
    • Our Culture
    • Join us

press release 2022

  1. Home>
  2. press release 2022

Press Release 2022

  • Post author:vcansupport
  • Post published:June 2, 2022
  • Post category:press release 2022
  • Post comments:0 Comments

Press Release | 20 April, 2022 Glenmark Life Sciences reports revenue growth of 10% YoY for Q4 FY22; 12.6% for the full year, FY22 READ MORE Press Release | 8…

Continue ReadingPress Release 2022

Recent Posts

  • Press Release 2021
  • Press Release 2022

Recent Comments

No comments to show.

Archives

  • June 2022

Categories

  • Press Release 2021
  • press release 2022
logo_alivus
  • HOME
  • ABOUT US
  • SOLUTIONS AND SERVICES
  • INFRASTRUCTURE
  • SUSTAINABILITY
  • INVESTORS
  • MEDIA
  • CAREERS
  • CONTACT US

Copyright © 2025, All Rights Reserved